News
Spectre of 'favoured nation' pricing manifests again in US
President Donald Trump is rumoured to be resurrecting a policy …
20858 items found
News
Shionogi aims to buy tobacco giant's pharma unit for $1bn
Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to …
News
RFK Jr launches database project to explore autism causes
Robert F Kennedy Jr has launched a project to trawl federal databases …
Market Access
Health equity can be a competitive advantage: What pharma leaders need to know
As NICE begins to incorporate health equity into drug reimbursement …
News
New data could move Enhertu into early breast cancer
AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been …
News
UK trumpets a trade deal with India - but pharma isn't happy
Various industry bodies have welcomed news of a trade deal between …
News
AI trained on NHS data 'may predict ill health in advance'
An artificial intelligence model that is being trained on …
News
FDA ramps up unannounced inspections of foreign facilities
The FDA has said it will expand unannounced inspections of overseas …
News
Vinay Prasad will replace Marks as CBER director
Controversial doctor Vinay Prasad, a public health researcher at UCSF …
Patients
Co-developing companion diagnostics to connect patients with emerging therapies
Companion diagnostic (CDx) tests play a critical role in …
News
Trump backs Biden-era abortion pill defence
The Trump administration has intervened in a long-running lawsuit …
News
Despite US turmoil, Hinge Health pushes ahead with IPO
Digital therapeutics (DTx) developer Hinge Health has published a new …
R&D
Modelling biologics: Challenges and opportunities, with Dr D...
From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Digital
AI-powered drug discovery is outpacing regulators, with Eric...
During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
Patients
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
Sales & Marketing
Partner Content
The ESG in Life Sciences Summit is coming to the West Coast!
The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).